Seminars in Pediatric Neurology
Volume 14, Issue 3 , Pages 108-117 , September 2007

The Overlapping Spectrum of Rett and Angelman Syndromes: A Clinical Review

  • Kerry Baldwin Jedele, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Kerry Baldwin Jedele, MD, Gundersen Lutheran Medical Center; C01-011; 1900 South Avenue; La Crosse, WI 54601.

References 

  1. Van den Veyver IB, Zoghbi HY. Genetic basis of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002;8:82–86
  2. Laurvick CL, de Klerk N, Bower C, et al. Rett syndrome in Australia: A review of the epidemiology. J Pediatr. 2006;148:347–352
  3. Hagberg B. Rett syndrome: Swedish approach to analysis of prevalence and cause. Brain Dev. 1985;7:276–280
  4. Hagberg B, Hanefeld F, Percy A, et al. An update on clinically applicable diagnostic criteria in Rett syndrome (Comments to Rett syndrome Clinical Criteria Consensus Panel satellite to European Paediatric Neurology Society meeting, Baden Baden, Germany, 11 September 2001). Eur J Paediatr Neurol. 2002;6:293–297
  5. Hagberg B. Clinical manifestations and stages of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002;8:61–65
  6. Einspieler C, Kerr AM, Prechtl HF. Is the early development of girls with Rett disorder really normal. Pediatr Res. 2005;57:696–700
  7. Nomura Y. Early behavior characteristics and sleep disturbance in Rett syndrome. Brain Dev. 2005;27(suppl 1):S35–S42
  8. Nomura Y, Segawa M. Natural history of Rett syndrome. J Child Neurol. 2005;20:764–768
  9. Hagberg G, Stenbom Y, Witt Engerstrom I. Head growth in Rett syndrome. Acta Paediatr. 2000;89:198–202
  10. Steffenburg U, Hagberg G, Hagberg B. Epilepsy in a representative series of Rett syndrome. Acta Paediatr. 2001;90:34–39
  11. Erlandson A, Hagberg B. MECP2 abnormality phenotypes: Clinicopathologic area with broad variability. J Child Neurol. 2005;20:727–732
  12. Larsson G, Lindstrom B, Engerstrom IW. Rett syndrome from a family perspective: The Swedish Rett Center survey. Brain Dev. 2005;27(suppl 1):S14–S19
  13. Witt-Engerstrom I. Rett syndrome: A retrospective pilot study on potential early predictive symptomatology. Brain Dev. 1987;9:481–486
  14. Hagberg B. Rett syndrome: Long-term clinical follow-up experiences over four decades. J Child Neurol. 2005;20:722–727
  15. Percy AK, Lane JB. Rett syndrome: Model of neurodevelopmental disorders. J Child Neurol. 2005;20:718–721
  16. Lavas J, Slotte A, Jochym-Nygren M, et al. Communication and eating proficiency in 125 females with Rett syndrome: The Swedish Rett center survey. Disabil Rehabil. 2006;28:1267–1279
  17. Deidrick KM, Percy AK, Schanen NC, et al. Rett syndrome: Pathogenesis, diagnosis, strategies, therapies, and future research directions. J Child Neurol. 2005;20:708–717
  18. Weese-Mayer DE, Lieske SP, Boothby CM, et al. Autonomic nervous system dysregulation: Breathing and heart rate perturbation during wakefulness in young girls with Rett syndrome. Pediatr Res. 2006;60:443–449
  19. Goyal M, O’Riordan MA, Wiznitzer M. Effect of topiramate on seizures and respiratory dysrhythmia in Rett syndrome. J Child Neurol. 2004;19:588–591
  20. Smeets EE, Julu PO, van Waardenburg D, et al. Management of a severe forceful breather with Rett syndrome using carbogen. Brain Dev. 2006;28:625–632
  21. Percy AK, Glaze DG, Schultz RJ, et al. Rett syndrome: Controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 1994;35:464–470
  22. Julu PO, Kerr AM, Apartopoulos F, et al. Characterisation of breathing and associated central autonomic dysfunction in the Rett disorder. Arch Dis Child. 2001;85:29–37
  23. Kerr AM, Armstrong DD, Prescott RJ, et al. Rett syndrome: Analysis of deaths in the British survey. Eur Child Adolesc Psychiatry. 1997;6(suppl 1):71–74
  24. Guideri F, Acampa M, Hayek Y, et al. Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: Prevention of sudden death?. Pediatr Cardiol. 2005;26:574–577
  25. Motil KJ, Schultz RJ, Browning K, et al. Oropharyngeal dysfunction and gastroesophageal dysmotility are present in girls and women with Rett syndrome. J Pediatr Gastroenterol Nutr. 1999;29:31–37
  26. Motil KJ, Schultz RJ, Wong WW, et al. Increased energy expenditure associated with repetitive involuntary movement does not contribute to growth failure in girls with Rett syndrome. J Pediatr. 1998;132:228–233
  27. Piazza CC, Fisher W, Kiesewetter K, et al. Aberrant sleep patterns in children with the Rett syndrome. Brain Dev. 1990;12:488–493
  28. Piazza CC, Fisher W, Moser H. Behavioral treatment of sleep dysfunction in patients with the Rett syndrome. Brain Dev. 1991;13:232–237
  29. McArthur AJ, Budden SS. Sleep dysfunction in Rett syndrome: A trial of exogenous melatonin treatment. Dev Med Child Neurol. 1998;40:186–192
  30. Ellaway CJ, Peat J, Williams K, et al. Medium-term open label trial of L-carnitine in Rett syndrome. Brain Dev. 2001;23 Suppl 1:S85–S89
  31. Tofil NM, Buckmaster MA, Winkler MK, et al. Deep sedation with propofol in patients with Rett syndrome. J Child Neurol. 2006;21:857–860
  32. Jian L, Nagarajan L, de Klerk N, et al. Predictors of seizure onset in Rett syndrome. J Pediatr. 2006;149:542–547
  33. Glaze DG, Schultz RJ, Frost JD. Rett syndrome: Characterization of seizures versus non-seizures. Electroencephalogr Clin Neurophysiol. 1998;106:79–83
  34. Pardal-Fernandez JM, Jerez-Garcia P, Onsurbe-Ramirez I, et al. Rett syndrome: A case presenting with atypical seizures (Neurophysiological and clinical aspects). Neurophysiol Clin. 2004;34:49–57
  35. Glaze DG. Neurophysiology of Rett syndrome. Ment Retard Dev Disabil Res Rev. 2002;8:66–71
  36. Armstrong DD. Neuropathology of Rett syndrome. J Child Neurol. 2005;20:747–753
  37. Huppke P, Kohler K, Brockmann K, et al. Treatment of epilepsy in Rett syndrome. Eur J Paediatr Neurol. 2007;11:10–16
  38. Siemes H, Brandl U, Helmstadter C, et al. Optimizing epilepsy therapy in children and adolescents with lamotrigine. Klin Padiatr. 2005;217:222–229
  39. Kumandas S, Caksen H, Ciftci A, et al. Lamotrigine in two cases of Rett syndrome. Brain Dev. 2001;23:240–242
  40. Stenbom Y, Tonnby B, Hagberg B. Lamotrigine in Rett syndrome: Treatment experience from a pilot study. Eur Child Adolesc Psychiatry. 1998;7:49–52
  41. Ramaekers VT, Hansen SI, Holm J, et al. Reduced folate transport to the CNS in female Rett patients. Neurology. 2003;61:506–515
  42. Neul JL, Maricich SM, Islam M, et al. Spinal fluid 5-methyltetrahydrofolate levels are normal in Rett syndrome. Neurology. 2005;64:2151–2152
  43. Giampietro PF, Schowalter DB, Merchant S, et al. Widened clinical spectrum of the Q128P MECP2 mutation in Rett syndrome. Childs Nerv Syst. 2006;22:320–324
  44. Liebhaber GM, Riemann E, Baumeister FA. Ketogenic diet in Rett syndrome. J Child Neurol. 2003;18:74–75
  45. Wilfong AA, Schultz RJ. Vagus nerve stimulation for treatment of epilepsy in Rett syndrome. Dev Med Child Neurol. 2006;48:683–686
  46. Milani D, Pantaleoni C, D’Arrigo S, et al. Another patient with MECP2 mutation without classic Rett syndrome phenotype. Pediatr Neurol. 2005;32:355–357
  47. Watson P, Black G, Ramsden S, et al. Angelman syndrome phenotype associated with mutations in MECP2, a gene encoding a methyl CpG binding protein. J Med Genet. 2001;38:224–228
  48. Heilstedt HA, Shahbazian MD, Lee B. Infantile hypotonia as a presentation of Rett syndrome. Am J Med Genet. 2002;111:238–242
  49. Huppke P, Held M, Laccone F, et al. The spectrum of phenotypes in females with Rett syndrome. Brain Dev. 2003;25:346–351
  50. Carney RM, Wolpert CM, Ravan SA, et al. Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr Neurol. 2003;28:205–211
  51. Hoffbuhr KC, Moses LM, Jerdonek MA, et al. Associations between MeCP2 mutations (X-chromosome inactivation, and phenotype). Ment Retard Dev Disabil Res Rev. 2002;8:99–105
  52. Huppke P, Maier EM, Warnke A, et al. Very mild cases of Rett syndrome with skewed X inactivation. J Med Genet. 2006;43:814–816
  53. Villard L. MECP2 mutations in males. J Med Genet. 2007;44:417–423
  54. del Gaudio D, Fang P, Scaglia F, et al. Increased MECP2 gene copy number as the result of genomic duplication in neurodevelopmentally delayed males. Genet Med. 2006;8:784–792
  55. Weaving LS, Christodoulou J, Williamson SL, et al. Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation. Am J Hum Genet. 2004;75:1079–1093
  56. Li MR, Pan H, Bao XH, et al. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome. J Hum Genet. 2007;52:38–47
  57. Mari F, Azimonti S, Bertani I, et al. CDKL5 belongs to the same molecular pathway of MeCP2 and it is responsible for the early-onset seizure variant of Rett syndrome. Hum Mol Genet. 2005;14:1935–1946
  58. Evans JC, Archer HL, Colley JP, et al. Early onset seizures and Rett-like features associated with mutations in CDKL5. Eur J Hum Genet. 2005;13:1113–1120
  59. Archer HL, Evans J, Edwards S, et al. CDKL5 mutations cause infantile spasms, early onset seizures, and severe mental retardation in female patients. J Med Genet. 2006;43:729–734
  60. Borg I, Freude K, Kubart S, et al. Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome. Eur J Hum Genet. 2005;13:921–927
  61. Archer HL, Evans JC, Millar DS, et al. NTNG1 mutations are a rare cause of Rett syndrome. Am J Med Genet A. 2006;140:691–694
  62. Schanen NC, Dahle EJ, Capozzoli F, et al. A new Rett syndrome family consistent with X-linked inheritance expands the X chromosome exclusion map. Am J Hum Genet. 1997;61:634–641
  63. Trappe R, Laccone F, Cobilanschi J, et al. MECP2 mutations in sporadic cases of Rett syndrome are almost exclusively of paternal origin. Am J Hum Genet. 2001;68:1093–1101
  64. Zeev BB, Yaron Y, Schanen NC, et al. Rett syndrome: Clinical manifestations in males with MECP2 mutations. J Child Neurol. 2002;17:20–24
  65. Mari F, Caselli R, Russo S, et al. Germline mosaicism in Rett syndrome identified by prenatal diagnosis. Clin Genet. 2005;67:258–260
  66. Evans JC, Archer HL, Whatley SD, et al. Germline mosaicism for a MECP2 mutation in a man with two Rett daughters. Clin Genet. 2006;70:336–338
  67. Villard L, Kpebe A, Cardoso C, et al. Two affected boys in a Rett syndrome family: Clinical and molecular findings. Neurology. 2000;55:1188–1193
  68. Bienvenu T, Carrie A, de Roux N, et al. MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum Mol Genet. 2000;9:1377–1384
  69. Laccone F, Junemann I, Whatley S, et al. Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum Mutat. 2004;23:234–244
  70. GeneReviews: MECP2-Related Disorders. Available at: http://www.genetests.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=Huc8KUbFYXpYV&gry=&fcn=y&fw=cSFS&filename=/profiles/rett/index.html. Accessed April 13, 2007
  71. Kyllerman M. On the prevalence of Angelman syndrome. Am J Med Genet. 1995;59:405
  72. Guerrini R, Carrozzo R, Rinaldi R, et al. Angelman syndrome: Etiology, clinical features, diagnosis, and management of symptoms. Paediatr Drugs. 2003;5:647–661
  73. Williams CA, Beaudet AL, Clayton-Smith J, et al. Angelman syndrome 2005: Updated consensus for diagnostic criteria. Am J Med Genet A. 2006;140:413–418
  74. Lossie AC, Whitney MM, Amidon D, et al. Distinct phenotypes distinguish the molecular classes of Angelman syndrome. J Med Genet. 2001;38:834–845
  75. Zori RT, Hendrickson J, Woolven S, et al. Angelman syndrome: Clinical profile. J Child Neurol. 1992;7:270–280
  76. Thomson AK, Glasson EJ, Bittles AH. A long-term population-based clinical and morbidity profile of Angelman syndrome in western Australia: 1953-2003. Disabil Rehabil. 2006;28:299–305
  77. Andersen WH, Rasmussen RK, Stromme P. Levels of cognitive and linguistic development in Angelman syndrome: A study of 20 children. Logoped Phoniatr Vocol. 2001;26:2–9
  78. Clayton-Smith J, Laan L. Angelman syndrome: A review of the clinical and genetic aspects. J Med Genet. 2003;40:87–95
  79. Barry RJ, Leitner RP, Clarke AR, et al. Behavioral aspects of Angelman syndrome: A case control study. Am J Med Genet A. 2005;132:8–12
  80. Peters SU, Beaudet AL, Madduri N, et al. Autism in Angelman syndrome: Implications for autism research. Clin Genet. 2004;66:530–536
  81. Guerrini R, De Lorey TM, Bonanni P, et al. Cortical myoclonus in Angelman syndrome. Ann Neurol. 1996;40:39–48
  82. Smith JC. Angelman syndrome: Evolution of the phenotype in adolescents and adults. Dev Med Child Neurol. 2001;43:476–480
  83. Varela MC, Kok F, Otto PA, et al. Phenotypic variability in Angelman syndrome: Comparison among different deletion classes and between deletion and UPD subjects. Eur J Hum Genet. 2004;12:987–992
  84. Miano S, Bruni O, Elia M, et al. Sleep breathing and periodic leg movement pattern in Angelman syndrome: A polysomnographic study. Clin Neurophysiol. 2005;116:2685–2692
  85. Didden R, Korzilius H, Smits MG, et al. Sleep problems in individuals with Angelman syndrome. Am J Ment Retard. 2004;109:275–284
  86. Zhdanova IV, Wurtman RJ, Wagstaff J. Effects of a low dose of melatonin on sleep in children with Angelman syndrome. J Pediatr Endocrinol Metab. 1999;12:57–67
  87. Bujok G, Knapik P. Angelman syndrome as a rare anaesthetic problem. Paediatr Anaesth. 2004;14:281–283
  88. Laan LA, den Boer AT, Hennekam RC, et al. Angelman syndrome in adulthood. Am J Med Genet. 1996;66:356–360
  89. Lossie AC, Driscoll DJ. Transmission of Angelman syndrome by an affected mother. Genet Med. 1999;1:262–266
  90. Rufa A, Dotti MT, Orrico A, et al. Retinochoroidal atrophy in two adult patients with Angelman syndrome. Am J Med Genet A. 2003;122:155–158
  91. Laan LA, Renier WO, Arts WF, et al. Evolution of epilepsy and EEG findings in Angelman syndrome. Epilepsia. 1997;38:195–199
  92. Valente KD, Koiffmann CP, Fridman C, et al. Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13. Arch Neurol. 2006;63:122–128
  93. Laan LA, Vein AA. Angelman syndrome: Is there a characteristic EEG. Brain Dev. 2005;27:80–87
  94. Valente KD, Andrade JQ, Grossmann RM, et al. Angelman syndrome: Difficulties in EEG pattern recognition and possible misinterpretations. Epilepsia. 2003;44:1051–1063
  95. Galvan-Manso M, Campistol J, Conill J, et al. Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome. Epileptic Disord. 2005;7:19–25
  96. Franz DN, Glauser TA, Tudor C, et al. Topiramate therapy of epilepsy associated with Angelman’s syndrome. Neurology. 2000;54:1185–1188
  97. Nolt DH, Mott JM, Lopez WL. Assessment of anticonvulsant effectiveness and safety in patients with Angelman’s syndrome using an internet questionnaire. Am J Health Syst Pharm. 2003;60:2583–2587
  98. Ostergaard JR, Balslev T. Efficacy of different antiepileptic drugs in children with Angelman syndrome associated with 15q11-13 deletion: The Danish experience. Dev Med Child Neurol. 2001;43:718–719
  99. Jiang SL, Bao XH, Song FY, et al. X chromosome inactivation patterns in patients with Rett syndrome and their mothers and the parental origin of the priority inactive X chromosome. Zhonghua Er Ke Za Zhi. 2006;44:648–652
  100. Molfetta GA, Munoz MV, Santos AC, et al. Discordant phenotypes in first cousins with UBE3A frameshift mutation. Am J Med Genet A. 2004;127:258–262
  101. Fung DC, Yu B, Cheong KF, et al. UBE3A “mutations” in two unrelated and phenotypically different Angelman syndrome patients. Hum Genet. 1998;102:487–492
  102. De Molfetta GA, Felix TM, Riegel M, et al. A further case of a Prader-Willi syndrome phenotype in a patient with Angelman syndrome molecular defect. Arq Neuropsiquiatr. 2002;60:1011–1014
  103. GeneReviews: Angelman Syndrome. Available at: http://www.genetests.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=Huc8KUbFYXpYV&gry=&fcn=y&fw=Bd2j&filename=/profiles/angelman/index.html. Accessed April 13, 2007
  104. Ludwig M, Katalinic A, Gross S, et al. Increased prevalence of imprinting defects in patients with Angelman syndrome born to subfertile couples. J Med Genet. 2005;42:289–291
  105. Kleefstra T, Yntema HG, Nillesen WM, et al. MECP2 analysis in mentally retarded patients: Implications for routine DNA diagnostics. Eur J Hum Genet. 2004;12:24–28
  106. LaSalle JM, Hogart A, Thatcher KN. Rett syndrome: A Rosetta Stone for understanding the molecular pathogenesis of autism. Int Rev Neurobiol. 2005;71:131–165
  107. Samaco RC, Nagarajan RP, Braunschweig D, et al. Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum Mol Genet. 2004;13:629–639
  108. Samaco RC, Hogart A, LaSalle JM. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. Hum Mol Genet. 2005;14:483–492
  109. Chen WG, Chang Q, Lin Y, et al. Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science. 2003;302:885–889
  110. Jay V, Becker LE, Chan FW, et al. Puppet-like syndrome of Angelman: A pathologic and neurochemical study. Neurology. 1991;41:416–422
  111. Giacometti E, Luikenhuis S, Beard C, et al. Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2. Proc Natl Acad Sci U S A. 2007;104:1931–1936
  112. Guy J, Gan J, Selfridge J, et al. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315:1143–1147
  113. Kishi N, Macklis JD. Dissecting MECP2 function in the central nervous system. J Child Neurol. 2005;20:753–759
  114. Cooper EM, Hudson AW, Amos J, et al. Biochemical analysis of Angelman syndrome-associated mutations in the E3 ubiquitin ligase E6-associated protein. J Biol Chem. 2004;279:41208–41217
  115. Glaze DG. Neurophysiology of Rett syndrome. J Child Neurol. 2005;20:740–746
  116. Moser SJ, Weber P, Lutschg J. Rett syndrome: Clinical and electrophysiologic aspects. Pediatr Neurol. 2007;36:95–100
  117. Clayton-Smith J. Clinical research on Angelman syndrome in the United Kingdom: observations on 82 affected individuals. Am J Med Genet. 1993;46:12–15

PII: S1071-9091(07)00048-4

doi: 10.1016/j.spen.2007.07.002

Seminars in Pediatric Neurology
Volume 14, Issue 3 , Pages 108-117 , September 2007

Article Tools

* Image Usage & Resolution